The persistence of silodosin monotherapy and the reasons for withdrawal from treatment of previously untreated Japanese patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia

The persistence of silodosin monotherapy and the reasons for withdrawal from treatment of previously untreated Japanese patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia - Persistence and withdrawal of silodosinn

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000026910

Enrollment

100

Registered

2017-04-10

Start date

2007-05-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign prostatic hyperplasia

Interventions

None listed

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Previously untreated Japanese patients aged 50 years or older who visited the hospital for lower urinary tract symptoms and were clinically diagnosed with benign prostatic hyperplasia

Exclusion criteria

Exclusion criteria: Patients with a urinary tract infection, acute urinary retention, prostate cancer or neurogenic bladder, the use of an alpha-1 adrenoceptor antagonist or anti-androgen, and a history of prostatic surgery were excluded from this study.

Design outcomes

Primary

Measure	Time frame
The persistence of silodosin use and the reasons for withdrawal from treatment of previously untreated Japanese patients with benign prostatic hyperplasia	—

Countries

Japan

Contacts

Public ContactYoshinori Tanaka

Hokkaido Prefectural Esashi Hospital Division of Urology

rinoshiyokanata@me.com0139-52-0036

Outcome results